Occupational exposure to aluminum and its biomonitoring in perspective

Critical Reviews in Toxicology

Volumn 42, Issue 10, 2012, Pages 827-853

  Riihimäki, Vesa ^a   Aitio, Antero ^a  

^a FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

Author keywords

Action limit value; Concentration in serum; Concentration in urine; Finely divided particles; Inhalation toxicokinetics; Lung burden; Neurotoxicity; Powder production; Sparsely soluble species; Welding

Indexed keywords

ALUMINUM; ALUMINUM OXIDE; CHOLINERGIC RECEPTOR; CREATININE; DRINKING WATER;

BIOLOGICAL MONITORING; BLOOD BRAIN BARRIER; BONE DISEASE; BONE FRAGILITY; BRAIN DISEASE; CHOLINERGIC TRANSMISSION; COGNITIVE DEFECT; DEMENTIA; DIALYSIS ENCEPHALOPATHY SYNDROME; DIALYSIS OSTEOMALACIA; DUST; HEALTH HAZARD; HEMATOPOIESIS; HISTOPATHOLOGY; HUMAN; INDUSTRY; INHALATION; KIDNEY FAILURE; LUNG ALVEOLITIS; LUNG DISEASE; LUNG FIBROSIS; NEUROTOXICITY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL SAFETY; REVIEW; THERMAL SPRAYING; TOXICOKINETICS; TRABECULAR BONE; URINARY ALUMINUM; URINE LEVEL; WELDING;

ALUMINUM; ALUMINUM COMPOUNDS; ANIMALS; BONE AND BONES; BRAIN; DEMENTIA; DRINKING WATER; ENVIRONMENTAL MONITORING; HEMATOPOIESIS; HUMANS; INHALATION EXPOSURE; LUNG; OCCUPATIONAL EXPOSURE; TOXICITY TESTS; WELDING;

EID: 84867560796     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.3109/10408444.2012.725027     Document Type: Review

References (180)

1. Aitio A, Bernard A, Fowler B, Nordberg G. (2007). Chapter 4.Biological monitoring and biomarkers. In: Nordberg G, Fowler B, Nordberg M, Friberg L, eds. Handbook on the Toxicology of Metals. Third edition. Amsterdam: Academic Press Elsevier, 65-78
2. Aitio A, Riihimäki V, Valkonen S. (1996). Aluminum. In: Lehtinen S, ed. Biological Monitoring of Chemical Exposure in the Workplace. Geneva: World Health Organization, 1-17
3. Aitio A, Santonen T. (2008). Establishment of biomonitoring action levels in the FIOH and a model for the interpretation of biomonitroing results (In Finnish) Biomonitoroinnin toimenpiderajojen tuottaminen Työ terveyslaitoksella sekä malli biomonitorointitulosten tulkintaan. Helsinki: Finnish Institute of Occupational Health.
4. Akila R, Stollery BT, Riihimäki V. (1999). Decrements in cognitive performance in metal inert gas welders exposed to aluminium. Occup Environ Med 56:632-639
5. Albers JW, Kallenbach LR, Fine LJ, Langolf GD, Wolfe RA, Donofrio PD, Alessi AG, Stolp-Smith KA, Bromberg MB. (1988). Neurological abnormalities associated with remote occupational elemental mercury exposure. Ann Neurol 24:651-659
6. Alfrey AC, Hegg A, Craswell P. (1980). Metabolism and toxicity of aluminum in renal failure. Am J Clin Nutr 33:1509-1516
7. Alfrey AC, LeGendre GR, Kaehny WD. (1976). The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med 294:184-188
8. Alfrey AC. (1980). Aluminum metabolism in uremia. Neurotoxicology 1:43-53
9. Altmann P, Dhanesha U, Hamon C, Cunningham J, Blair J, Marsh F. (1989). Disturbance of cerebral function by aluminium in haemodialysis patients without overt aluminium toxicity. Lancet 2:7-12
10. Araki S. (1980). Effects of urinary volume on urinary concentrations of lead, ?-aminolaevulinic acid, coproporphyrin, creatinine, and total solutes. Br J Ind Med 37:50-54
11. Araki S, Sata F, Murata K. (1990). Units of determinans in urine. In: Fisherova-Bergerova V, Ogata M, eds. Biological Monitoring of Exposure to Industrial Chemicals. Cincinnati, OH: ACGIH, 203-212
12. Armstrong B, Hutchinson E, Unwin J, Fletcher T. (2004). Lung cancer risk after exposure to polycyclic aromatic hydrocarbons: a review and meta-analysis. Environ Health Perspect 112:970-978
13. Aslam, Davis K, Pejovic-Milic A, Chettle DR. (2009). Noninvasive measurement of aluminium in human bone: preliminary human study and improved system performance. J Inorg Biochem 103:1585-1590
14. ATSDR. (2008). Toxicological profile for aluminum. US Department for Health and Human Services. Public Health Service Agency for Toxic Substances and Disease Registry. Available at: http://www.atsdr.cdc.gov/ToxProfiles/tp22.pdf
15. Bast-Pettersen R, Drabløs PA, Goffeng LO, Thomassen Y, Torres CG. (1994). Neuropsychological deficit among elderly workers in aluminum production. Am J Ind Med 25:649-662
16. Bast-Pettersen R, Skaug V, Ellingsen D, Thomassen Y. (2000). Neurobehavioral performance in aluminum welders. Am J Ind Med 37:184-192
17. Bia MJ, Cooper K, Schnall S, Duffy T, Hendler E, Malluche H, Solomon L. (1989). Aluminum induced anemia: pathogenesis and treatment in patients on chronic hemodialysis. Kidney Int 36:852-858
18. Bolla KI, Briefel G, Spector D, Schwartz BS, Wieler L, Herron J, Gimenez L. (1992). Neurocognitive effects of aluminum. Arch Neurol 49:1021-1026
19. Buchta M, Kiesswetter E, Otto A, Schaller KH, Seeber A, Hilla W, Windorfer K, Stork J, Kuhlmann A, Gefeller O, Letzel S. (2003). Longitudinal study examining the neurotoxicity of occupational exposure to aluminium-containing welding fumes. Int Arch Occup Environ Health 76:539-548
20. Buchta M, Kiesswetter E, Schäper M, Zschiesche W, Schaller K, Kuhlmann A, Letzel S. (2005). Neurotoxicity of exposures to aluminium welding fumes in the truck trailer construction industry. Env Toxicol Pharmacol 19:677-685
21. Cannata Andia J, Diaz Lopez J. (1990). The diagnosis of aluminium toxicity. In: Debroe M, Coburn L, eds. Aluminum and Renal Failure. Dordrecht: Kluwer Academic Publishers, 289-308
22. Caramelo CA, Cannata JB, Rodeles MR, Fernández Martín JL, Mosquera JR, Monzú B, Outeiriño J, Blum G, Andrea C, Lopez Farrø AJ. (1995). Mechanisms of aluminum-induced microcytosis: lessons from accidental aluminum intoxication. Kidney Int 47:164-168
23. Carrieri M, Trevisan A, Bartolucci GB. (2001). Adjustment to concentrationdilution of spot urine samples: correlation between specific gravity and creatinine. Int Arch Occup Environ Health 74:63-67
24. CEN European Committee for Standardisation. (1993). Workplace atmospheres -size fraction definitions for measurement of airborne particles. CEN Standard EN 481, Brussels: CEN European Committee for Standardisation.
25. Chadwick JK, Wilson HK, White MA. (1997). An investigation of occupational metal exposure in thermal spraying processes. Sci Total Environ 199:115-124
26. Chen WJ, Monnat RJ Jr, Chen M, Mottet NK. (1978). Aluminum induced pulmonary granulomatosis. Hum Pathol 9:705-711
27. Consensus conference. (1993). Diagnosis and treatment of aluminium overload in end-stage renal failure patients. Nephrol Dial Transplant 8 Suppl 1:1-54
28. Dasch J, D'Arcy J. (2008). Physical and chemical characterization of airborne particles from welding operations in automotive plants. J Occup Environ Hyg 5:444-454
29. Davis K, Aslam, Pejovic-Milic A, Chettle DR. (2008). In vivo measurement of bone aluminum in population living in southern Ontario, Canada. Med Phys 35:5115-5123
30. De Vuyst P, Dumortier P, Rickaert F, Van de Weyer R, Lenclud C, Yernault JC. (1986). Occupational lung fibrosis in an aluminium polisher. Eur J Respir Dis 68:131-140
31. Elihn K, Berg P. (2009). Ultrafine particle characteristics in seven industrial plants. Ann Occup Hyg 53:475-484
32. Elinder CG, Ahrengart L, Lidums V, Pettersson E, Sjögren B. (1991). Evidence of aluminium accumulation in aluminium welders. Br J Ind Med 48:735-738
33. Flarend R, Bin T, Elmore D, Hem SL. (2001). A preliminary study of the dermal absorption of aluminium from antiperspirants using aluminium-26. Food Chem Toxicol 39:163-168
34. Flaten T. (1990). Geographical associations between aluminium in drinking water and death rates with dementia (including Alzheimer's disease), Parkinson's disease and amyotrophic lateral sclerosis in Norway. Environ Geochem Health 12
35. Forbes W, Hayward L, Agwani N. (1992). Geochemical risk factors for mental functioning, based on the Ontario Longitudinal Study of Aging (LAS). I. Results from a preliminary investigation. Can J Aging 11:269-280
36. Forbes W, Lessard S, Gentleman J. (1995). Geochemical risk factors for mental functioning, based on the Ontario Longitudinal Study of Aging (LSA) V. Comparisons of the results, relevant to aluminum water concentrations, obtained from the LSA and from death certificates mentioning dementia. Can J Aging 14:642-656
37. Forster DP, Newens AJ, Kay DW, Edwardson JA. (1995). Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: a case-control study in northern England. J Epidemiol Community Health 49:253-258
38. Frecker MF. (1991). Dementia in Newfoundland: identification of a geographical isolate? J Epidemiol Community Health 45:307-311
39. Gauthier E, Fortier I, Courchesne F, Pepin P, Mortimer J, Gauvreau D. (2000). Aluminum forms in drinking water and risk of Alzheimer's disease. Environ Res 84:234-246
40. Geiser M, Rothen-Rutishauser B, Kapp N, Schürch S, Kreyling W, Schulz H, Semmler M, Im Hof V, Heyder J, Gehr P. (2005). Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113:1555-1560
41. Gitelman HJ, Alderman FR, Kurs-Lasky M, Rockette HE. (1995). Serum and urinary aluminium levels of workers in the aluminium industry. Ann Occup Hyg 39:181-191
42. Gitelman HJ. (1995). Aluminum exposure and excretion. Sci Total Environ 163:129-135
43. Greenberg GN, Levine RJ. (1989). Urinary creatinine excretion is not stable: a new method for assessing urinary toxic substance concentrations. J Occup Med 31:832-838
44. Greger JL, Sutherland JE. (1997). Aluminum exposure and metabolism. Crit Rev Clin Lab Sci 34:439-474
45. Gun RT, Korten AE, Jorm AF, Henderson AS, Broe GA, Creasey H, McCusker E, Mylvaganam A. (1997). Occupational risk factors for Alzheimer disease: a case-control study. Alzheimer Dis Assoc Disord 11:21-27
46. Gurjar M, Baronia AK, Azim A, Sharma K. (2011). Managing aluminum phosphide poisonings. J Emerg Trauma Shock 4:378-384
47. Halatek T, Sinczuk-Walczak H, Rydzynski K. (2005). Prognostic significance of low serum levels of Clara cell phospholipid-binding protein in occupational aluminium neurotoxicity. J Inorg Biochem 99:1904-1911
48. Hänninen H, Matikainen E, Kovala T, Valkonen S, Riihimäki V. (1994). Internal load of aluminum and the central nervous system function of aluminum welders. Scand J Work Environ Health 20:279-285
49. Hannu T, Riihimäki V, Piirilä P. (2009). Reactive airway dysfunction syndrome (RADS) in a chemistry teacher induced by fumes of mixed iodine compounds. Ind Health 47:681-684
50. Hantson P, Mahieu P, Gersdorff M, Sindic CJ, Lauwerys R. (1994). Encephalopathy with seizures after use of aluminium-containing bone cement. Lancet 344:1647
51. Healy J, Bradley SD, Northage C, Scobbie E. (2001). Inhalation exposure in secondary aluminium smelting. Ann Occup Hyg 45:217-225
52. Hellström HO, Mjöberg B, Mallmin H, Michaëlsson K. (2005). The aluminum content of bone increases with age, but is not higher in hip fracture cases with and without dementia compared to controls. Osteoporos Int 16:1982-1988
53. Hellström HO, Mjöberg B, Mallmin H, Michaëlsson K. (2006). No association between the aluminium content of trabecular bone and bone density, mass or size of the proximal femur in elderly men and women. BMC Musculoskelet Disord 7:69
54. Heyder J. (2004). Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc Am Thorac Soc 1:315-320
55. Hosovski E, Mastelica Z, Sunderic D, Radulovic D. (1990). Mental abilities of workers exposed to aluminium. Med Lav 81:119-123
56. Hostynek JJ, Hinz RS, Lorence CR, Price M, Guy RH. (1993). Metals and the skin. Crit Rev Toxicol 23:171-235
57. Hull MJ, Abraham JL. (2002). Aluminum welding fume-induced pneumoconiosis. Hum Pathol 33:819-825
58. IARC. (1984). Polynuclear aromatic compounds, Part 3, Industrial exposures in aluminum production, coal gasification, coke production, and iron and steel founding. IARC Monographs on the Evaluation of Carcinogenic risks to humans Vol 34. Lyons: World Health Organization, International Agency for Research on Cancer.
59. ICRP. (1994). Human respiratory tract model for radiological protection. ICRP Publication 66. Ann ICRP 24 (1-3).
60. IPCS. (2006). Elemental speciation in human health risk assessment. Environmental Health Criteria 234. Geneva: International Programme on Chemical Safety, World Health Organization.
61. Iregren A, Sjögren B, Gustafsson K, Hagman M, Nyløn L, Frech W, Andersson M, Ljunggren KG, Wennberg A. (2001). Effects on the nervous system in different groups of workers exposed to aluminium. Occup Environ Med 58:453-460
62. Jacqmin H, Commenges D, Letenneur L, Barberger-Gateau P, Dartigues JF. (1994). Components of drinking water and risk of cognitive impairment in the elderly. Am J Epidemiol 139:48-57
63. Jacqmin-Gadda H, Commenges D, Letenneur L, Dartigues JF. (1996). Silica and aluminum in drinking water and cognitive impairment in the elderly. Epidemiology 7:281-285
64. Jakubowski M, Trzcinka-Ochocka M, Ra?niewska G. (2000). Biological monitoring of occupational and environmental exposure to metals: determination methods and result interpretation. ?ód?: Nofer Institute of Occupational Health.
65. Jaques PA, Kim CS. (2000). Measurement of total lung deposition of inhaled ultrafine particles in healthy men and women. Inhal Toxicol 12:715-731
66. Jing Y, Wang Z, Song Y. (2004). Quantitative study of aluminum-induced changes in synaptic ultrastructure in rats. Synapse 52:292-298
67. Jordan J. (1961). Pulmonary fibrosis in a worker using an aluminium powder. Br J Ind Med 18:21-23
68. Julka D, Sandhir R, Gill KD. (1995). Altered cholinergic metabolism in rat CNS following aluminum exposure: implications on learning performance. J Neurochem 65:2157-2164
69. Kiesswetter E, Schäper M, Buchta M, Schaller KH, Rossbach B, Kraus T, Letzel S. (2009). Longitudinal study on potential neurotoxic effects of aluminium: II. Assessment of exposure and neurobehavioral performance of Al welders in the automobile industry over 4 years. Int Arch Occup Environ Health 82:1191-1210
70. Kiesswetter E, Schäper M, Buchta M, Schaller KH, Rossbach B, Scherhag H, Zschiesche W, Letzel S. (2007). Longitudinal study on potential neurotoxic effects of aluminium: I. Assessment of exposure and neurobehavioural performance of Al welders in the train and truck construction industry over 4 years. Int Arch Occup Environ Health 81:41-67
71. Kilburn KH. (1998). Neurobehavioral impairment and symptoms associated with aluminum remelting. Arch Environ Health 53:329-335
72. Kilburn KH. (1999). Does exposure to fine aluminium dust affect the brain? Lancet 354:1575-1577
73. Kraus T, Schaller KH, Angerer J, Hilgers RD, Letzel S. (2006). Aluminosis-detection of an almost forgotten disease with HRCT. J Occup Med Toxicol 1:4
74. Kraus T, Schaller KH, Angerer J, Letzel S. (2000). Aluminium dustinduced lung disease in the pyro-powder-producing industry: detection by high-resolution computed tomography. Int Arch Occup Environ Health 73:61-64
75. Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, Harry J, Kacew S, Lindsay J, Mahfouz AM, Rondeau V. (2007). Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J Toxicol Environ Health B Crit Rev 10 Suppl 1:1-269
76. Kumar V, Bal A, Gill KD. (2008). Impairment of mitochondrial energy metabolism in different regions of rat brain following chronic exposure to aluminium. Brain Res 1232:94-103
77. Kumar V, Gill KD. (2009). Aluminium neurotoxicity: neurobehavioural and oxidative aspects. Arch Toxicol 83:965-978
78. Ladurner G, Wawschinek O, Pogglitsch H, Petek W, Urlesberger H, Holzer H. (1982). Neurophysiological findings and serum aluminium in dialysis encephalopathy. Eur Neurol 21:335-339
79. Letzel S, Lang CJ, Schaller KH, Angerer J, Fuchs S, Neundörfer B, Lehnert G. (2000). Longitudinal study of neurotoxicity with occupational exposure to aluminum dust. Neurology 54:997-1000
80. Letzel S, Schaller K, Angerer J, Drexler H, Weber A, Schmid K, Weltle D. (1996). Biological monitoring of occupational aluminium powder exposure. Occup Hyg 3:271-280
81. Letzel S. (2007). Aluminium-, aluminiumoxid-und aluminiumhydroxidhaltige Stäube. In: Greim H, ed. Gesundheitsschädliche Arbeitsstoffe -Toxikologisch-arbeitsmedizinische Begründungen von MAKWerten. 43rd ed. Weinheim, FRG: Wiley-VCH.
82. Letzel S. (2009). Addendum zu Aluminium. In: Drexler H, Hartwig A, eds. Biologische Arbeitsstoff-Toleranz-Werte (BAT-Werte), Expositionsäquivalente für krebserzeugende Arbeitsstoffe (EKA), Biologische Leitwerte (BLW) und Biologische Arbeitsstoff-Referenzwerte (BAR). Weinheim, FRG: Wiley-VCH, 3-16
83. Ljunggren KG, Lidums V, Sjögren B. (1991). Blood and urine concentrations of aluminium among workers exposed to aluminium flake powders. Br J Ind Med 48:106-109
84. Longstreth WT Jr, Rosenstock L, Heyer NJ. (1985). Potroom palsy? Neurologic disorder in three aluminum smelter workers. Arch Intern Med 145:1972-1975
85. Lote CJ, Wood JA, Thewles A, Freeman M. (1995). Renal filtration and excretion of aluminium in the rat: dose-response relationships and effects of aluminium speciation. Hum Exp Toxicol 14:494-499
86. Markesbery WR, Ehmann WD, Alauddin M, Hossain TI. (1984). Brain trace element concentrations in aging. Neurobiol Aging 5:19-28
87. Martyn C, Barker D, Osmond C, Edwardson J, Harris E, Lacey R. (1989). Geographical relation between Alzheimer's disease and aluminium in drinking water. Lancet 333:61-62
88. Martyn CN, Coggon DN, Inskip H, Lacey RF, Young WF. (1997). Aluminum concentrations in drinking water and risk of Alzheimer's disease. Epidemiology 8:281-286
89. Matczak W, Gromiec J. (2002). Evaluation of occupational exposure to toxic metals released in the process of aluminum welding. Appl Occup Environ Hyg 17:296-303
90. Maynard RL, Donaldson K, Tetley TD. (2012). Type 1 pulmonary epithelial cells: a new compartment involved in the slow phase of particle clearance from alveoli. Nanotoxicology, Posted online on 31 January 31, 2012
91. McLachlan DR, Bergeron C, Smith JE, Boomer D, Rifat SL. (1996). Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories. Neurology 46:401-405
92. Mclaughlin AI, Kazantzis G, King E, Teared, Porter RJ, Owen R. (1962). Pulmonary fibrosis and encephalopathy associated with the inhalation of aluminium dust. Br J Ind Med 19:253-263
93. Meyer-Baron M, Schäper M, Knapp G, van Thriel C. (2007). Occupational aluminum exposure: evidence in support of its neurobehavioral impact. Neurotoxicology 28:1068-1078
94. Michalke B, Halbach S, Nischwitz V. (2009). JEM spotlight: metal speciation related to neurotoxicity in humans. J Environ Monit 11:939-954
95. Mila?i? R. (2005). Speciation of aluminum in clinical aspects (health & disease). In: Cornelis R, Crews H, Caruso J, Heumann K, eds. Handbook of Elemental Speciation II: Species in the Environment, Food, Medicine & Occupational Health. Chichester (UK): John Wiley & Sons, 27-39
96. Miller RR, Churg AM, Hutcheon M, Lom S. (1984). Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis 130:312-315
97. Mitchell J, Manning GB, Molyneux M, Lane RE. (1961). Pulmonary fibrosis in workers exposed to finely powdered aluminium. Br J Ind Med 18:10-23
98. Mitchell J. (1959). Pulmonary fibrosis in an aluminium worker. Br J Ind Med 16:123-125
99. Miu AC, Andreescu CE, Vasiu R, Olteanu AI. (2003). A behavioral and histological study of the effects of long-term exposure of adult rats to aluminum. Int J Neurosci 113:1197-1211
100. Miu AC, Olteanu AI, Miclea M. (2004). A behavioral and ultrastructural dissection of the interference of aluminum with aging. J Alzheimers Dis 6:315-328
101. Mladenovic J. (1988). Aluminum inhibits erythropoiesis in vitro. J Clin Invest 81:1661-1665
102. Molloy DW, Standish TI, Nieboer E, Turnbull JD, Smith SD, Dubois S. (2007). Effects of acute exposure to aluminum on cognition in humans. J Toxicol Environ Health Part A 70:2011-2019
103. Nagasawa K, Ito S, Kakuda T, Nagai K, Tamai I, Tsuji A, Fujimoto S. (2005). Transport mechanism for aluminum citrate at the bloodbrain barrier: kinetic evidence implies involvement of system Xc-in immortalized rat brain endothelial cells. Toxicol Lett 155:289-296
104. National Kidney Foundation. (2003). K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1-S201
105. Nemmar A, Hoet PH, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, Vanbilloen H, Mortelmans L, Nemery B. (2002). Passage of inhaled particles into the blood circulation in humans. Circulation 105:411-414
106. Neri LC, Hewitt D. (1991). Aluminium, Alzheimer's disease, and drinking water. Lancet 338:390
107. Nieboer E, Sanford W, Stacey B. (1992). Absorption, distribution, and excretion of nickel. In: Nieboer E, Nriagu O, eds. Nickel and Human Health Current Perspectives. New York: John Wiley & Sons, Inc, 49-68
108. Oberdorster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. (2004). Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437-445
109. Perez G, Garbossa G, Di Risio C, Vittori D, Nesse A. (2001). Disturbance of cellular iron uptake and utilisation by aluminium. J Inorg Biochem 87:21-27
110. Perl DP, Good PF. (1987). Uptake of aluminium into central nervous system along nasal-olfactory pathways. Lancet 1:1028
111. Phelps KR, Naylor K, Brien TP, Wilbur H, Haqqie SS. (1999). Encephalopathy after bladder irrigation with alum: case report and literature review. Am J Med Sci 318:181-185
112. Pierre F, Baruthio F, Diebold F, Biette P. (1995). Effect of different exposure compounds on urinary kinetics of aluminium and fluoride in industrially exposed workers. Occup Environ Med 52:396-403
113. Polizzi S, Pira E, Ferrara M, Bugiani M, Papaleo A, Albera R, Palmi S. (2002). Neurotoxic effects of aluminium among foundry workers and Alzheimer's disease. Neurotoxicology 23:761-774
114. Priest ND, Newton D, Day JP, Talbot RJ, Warner AJ. (1995). Human metabolism of aluminium-26 and gallium-67 injected as citrates. Hum Exp Toxicol 14:287-293
115. Priest ND, Talbot RJ, Austin JG, Day JP, King SJ, Fifield K, Cresswell RG. (1996). The bioavailability of 26Al-labelled aluminium citrate and aluminium hydroxide in volunteers. Biometals 9:221-228
116. Priest ND, Talbot RJ, Newton D, Day JP, King SJ, Fifield LK. (1998). Uptake by man of aluminium in a public water supply. Hum Exp Toxicol 17:296-301
117. Priest ND. (2004). The biological behaviour and bioavailability of aluminium in man, with special reference to studies employing aluminium-26 as a tracer: review and study update. J Environ Monit 6:375-403
118. Radziun E, Dudkiewicz Wilczynska J, Ksiazek I, Nowak K, Anuszewska EL, Kunicki A, Olszyna A, Zabkowski T. (2011). Assessment of the cytotoxicity of aluminium oxide nanoparticles on selected mammalian cells. Toxicol In Vitro 25:1694-1700
119. Renard JL, Felten D, Bøquet D. (1994). Post-otoneurosurgery aluminium encephalopathy. Lancet 344:63-64
120. Reusche E, Pilz P, Oberascher G, Lindner B, Egensperger R, Gloeckner K, Trinka E, Iglseder B. (2001). Subacute fatal aluminum encephalopathy after reconstructive otoneurosurgery: a case report. Hum Pathol 32:1136-1140
121. Ribes D, Colomina MT, Vicens P, Domingo JL. (2008). Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic mouse model of Alzheimer's disease. Exp Neurol 214:293-300
122. Rifat SL, Eastwood MR, McLachlan DR, Corey PN. (1990). Effect of exposure of miners to aluminium powder. Lancet 336:1162-1165
123. Riihimäki V, Hänninen H, Akila R, Kovala T, Kuosma E, Paakkulainen H, Valkonen S, Engström B. (2000). Body burden of aluminum in relation to central nervous system function among metal inert-gas welders. Scand J Work Environ Health 26:118-130
124. Riihimäki V, Valkonen S, Engström B, Tossavainen A, Mutanen P, Aitio A. (2008). Behavior of aluminum in aluminum welders and manufacturers of aluminum sulfate-impact on biological monitoring. Scand J Work Environ Health 34:451-462
125. Rogers MA, Simon DG. (1999). A preliminary study of dietary aluminium intake and risk of Alzheimer's disease. Age Ageing 28:205-209
126. Röllin HB, Theodorou P, Kilroe-Smith TA. (1991). Deposition of aluminium in tissues of rabbits exposed to inhalation of low concentrations of Al2O3 dust. Br J Ind Med 48:389-391
127. Rondeau V, Commenges D, Jacqmin-Gadda H, Dartigues JF. (2000). Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study. Am J Epidemiol 152:59-66
128. Rondeau V, Jacqmin-Gadda H, Commenges D, Helmer C, Dartigues JF. (2009). Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am J Epidemiol 169:489-496
129. Roskams AJ, Connor JR. (1990). Aluminum access to the brain: a role for transferrin and its receptor. Proc Natl Acad Sci USA 87:9024-9027
130. Rossbach B, Buchta M, Csanády GA, Filser JG, Hilla W, Windorfer K, Stork J, Zschiesche W, Gefeller O, Pfahlberg A, Schaller KH, Egerer E, Escobar Pinzón LC, Letzel S. (2006). Biological monitoring of welders exposed to aluminium. Toxicol Lett 162:239-245
131. Rovelli E, Luciani L, Pagani C, Albonico C, Colleoni N, D'Amico G. (1988). Correlation between serum aluminum concentration and signs of encephalopathy in a large population of patients dialyzed with aluminum-free fluids. Clin Nephrol 29:294-298
132. Salib E, Hillier V. (1996). A case-control study of Alzheimer's disease and aluminium occupation. Br J Psychiatry 168:244-249
133. Sata F, Araki S, Yokoyama K, Murata K. (1995). Adjustment of creatinineadjusted values in urine to urinary flow rate: a study of eleven heavy metals and organic substances. Int Arch Occup Environ Health 68:64-68
134. Sata F, Araki S. (1996). Adjustment of creatinine-adjusted value to urine flow rate in lead workers. Arch Environ Health 51:329-33; discussion 333
135. Schaller KH, Csanady G, Filser J, Jüngert B, Drexler H. (2007). Elimination kinetics of metals after an accidental exposure to welding fumes. Int Arch Occup Environ Health 80:635-641
136. Schmid K, Angerer J, Letzel S, Sturm G, Lehnert G. (1995). Use of bone mineral content determination by X-ray absorptiometry in the evaluation of osteodystrophy among workers exposed to aluminium powders. Sci Total Environ 163:147-151
137. Sethi P, Jyoti A, Singh R, Hussain E, Sharma D. (2008). Aluminiuminduced electrophysiological, biochemical and cognitive modifications in the hippocampus of aging rats. Neurotoxicology 29:1069-1079
138. Sharif AAM, Ghafourian H, Ahmadiniar A, Wagif Husain S, Saber-Tehrani M, Ghods H. (2004). Determination of aluminum levels in serum and red blood cells from long-term hemodialysis patients using instrumental neutron activation analysis. J Radioanal Nucl Chem 262:473-477
139. Shaver CG, Riddell AR. (1947). Lung changes associated with the manufacture of alumina abrasives. J Ind Hyg Toxicol 29:145-157
140. Shirley DG, Lote CJ. (2005). Renal handling of aluminium. Nephron Physiol 101:99-103
141. Sim M, Dick R, Russo J, Bernard B, Grubb P, Krieg E Jr, Mueller C, McCammon C. (1997). Are aluminium potroom workers at increased risk of neurological disorders? Occup Environ Med 54:229-235
142. Simonsson BG, Sjöberg A, Rolf C, Haeger-Aronsen B. (1985). Acute and long-term airway hyperreactivity in aluminium-salt exposed workers with nocturnal asthma. Eur J Respir Dis 66:105-118
143. Sinczuk-Walczak H, Szymczak M, Razniewska G, Matczak W, Szymczak W. (2003). Effects of occupational exposure to aluminum on nervous system: clinical and electroencephalographic findings. Int J Occup Med Environ Health 16:301-310
144. Sjögren B, Elinder C.-G, Iregren A, Crapper McLachlan D, Riihimäki V. (1997). Occupational aluminum exposure and its health effects. In: Yokel R, Golub M, eds. Research issues in aluminum toxicity. Washington: Taylor & Francis, 165-183
145. Sjögren B, Elinder CG, Lidums V, Chang G. (1988). Uptake and urinary excretion of aluminum among welders. Int Arch Occup Environ Health 60:77-79
146. Sjögren B, Gustavsson P, Hogstedt C. (1990). Neuropsychiatric symptoms among welders exposed to neurotoxic metals. Br J Ind Med 47:704-707
147. Sjögren B, Iregren A, Frech W, Hagman M, Johansson L, Tesarz M, Wennberg A. (1996). Effects on the nervous system among welders exposed to aluminium and manganese. Occup Environ Med 53:32-40
148. Sjögren B, Lidums V, Håkansson M, Hedström L. (1985). Exposure and urinary excretion of aluminum during welding. Scand J Work Environ Health 11:39-43
149. Sjögren B, Lundberg I, Lidums V. (1983). Aluminium in the blood and urine of industrially exposed workers. Br J Ind Med 40:301-304
150. Soyseth V, Kongerud J. (1992). Prevalence of respiratory disorders among aluminium potroom workers in relation to exposure to fluoride. Br J Ind Med 49:125-130
151. Spencer AJ, Wood JA, Saunders HC, Freeman MS, Lote CJ. (1995). Aluminium deposition in liver and kidney following acute intravenous administration of aluminium chloride or citrate in conscious rats. Hum Exp Toxicol 14:787-794
152. Steinhausen C, Kislinger G, Winklhofer C, Beck E, Hohl C, Nolte E, Ittel TH, Alvarez-Brückmann MJ. (2004). Investigation of the aluminium biokinetics in humans: a 26Al tracer study. Food Chem Toxicol 42:363-371
153. Swartz RD. (1985). Deferoxamine and aluminum removal. Am J Kidney Dis 6:358-364
154. Talbot RJ, Newton D, Priest ND, Austin JG, Day JP. (1995). Inter-subject variability in the metabolism of aluminium following intravenous injection as citrate. Hum Exp Toxicol 14:595-599
155. Tamada T. (2004). Fluorimetric determination of aluminum in human serum and whole blood. Bunseki Kagaku 53:435-440
156. Taylor GA, Newens AJ, Edwardson JA, Kay DW, Forster DP. (1995). Alzheimer's disease and the relationship between silicon and aluminium in water supplies in northern England. J Epidemiol Community Health 49:323-324
157. Valentin H, Preusser P, Schaller KH. (1976). The analyses of aluminum in serum and urine for monitoring of exposed persons. Int Arch Occup Environ Health 38:1-17
158. Valkonen S, Aitio A. (1997). Analysis of aluminium in serum and urine for the biomonitoring of occupational exposure. Sci Total Environ 199:103-110
159. Valkonen S, Riihimäki V. (2005). Speciation of aluminum in occupational health. In: Cornelis R, Crews H, Caruso J, Heumann K, eds. Handbook of elemental speciation II: species in the environment, food, medicine & occupational health. Chichester (UK): John Wiley & Sons, 40-46
160. Vallyathan V, Bergeron WN, Robichaux PA, Craighead JE. (1982). Pulmonary fibrosis in an aluminum arc welder. Chest 81:372-374
161. van der Voet GB, de Wolff FA. (1985). Distribution of aluminium between plasma and erythrocytes. Hum Toxicol 4:643-648
162. Vij HS, Howell S. (1998). Improving the specific gravity adjustment method for assessing urinary concentrations of toxic substances. Am Ind Hyg Assoc J 59:375-380
163. Viljakainen S, Visti A, Laakso S. (2002). Concentrations of organic acids and soluble sugars in juices from Nordic berries. Acta Agric Scand Secti B. Soil Plant Sci 52:101-109
164. Vittori D, Nesse A, Perez G, Garbossa G. (1999). Morphologic and functional alterations of erythroid cells induced by long-term ingestion of aluminium. J Inorg Biochem 76:113-120
165. Wettstein A, Aeppli J, Gautschi K, Peters M. (1991). Failure to find a relationship between mnestic skills of octogenarians and aluminum in drinking water. Int Arch Occup Environ Health 63:97-103
166. White DM, Longstreth WT Jr, Rosenstock L, Claypoole KH, Brodkin CA, Townes BD. (1992). Neurologic syndrome in 25 workers from an aluminum smelting plant. Arch Intern Med 152:1443-1448
167. Willhite CC, Ball GL, McLellan CJ. (2012). Total allowable concentrations of monomeric inorganic aluminum and hydrated aluminum silicates in drinking water. Crit Rev Toxicol 42:358-442
168. Woodson GC. (1998). An interesting case of osteomalacia due to antacid use associated with stainable bone aluminum in a patient with normal renal function. Bone 22:695-698
169. Yokel RA, Florence RL. (2006). Aluminum bioavailability from the approved food additive leavening agent acidic sodium aluminum phosphate, incorporated into a baked good, is lower than from water. Toxicology 227:86-93
170. Yokel RA, Florence RL. (2008). Aluminum bioavailability from tea infusion. Food Chem Toxicol 46:3659-3663
171. Yokel RA, Hicks CL, Florence RL. (2008). Aluminum bioavailability from basic sodium aluminum phosphate, an approved food additive emulsifying agent, incorporated in cheese. Food Chem Toxicol 46:2261-2266
172. Yokel RA, McNamara PJ. (2001). Aluminium toxicokinetics: an updated mini review. Pharmacol Toxicol 88:159-167
173. Yokel RA, Rhineheimer SS, Brauer RD, Sharma P, Elmore D, McNamara PJ. (2001a). Aluminum bioavailability from drinking water is very low and is not appreciably influenced by stomach contents or water hardness. Toxicology 161:93-101
174. Yokel RA, Rhineheimer SS, Sharma P, Elmore D, McNamara PJ. (2001b). Entry, half-life, and desferrioxamine-accelerated clearance of brain aluminum after a single (26)Al exposure. Toxicol Sci 64:77-82
175. Yokel RA, Wilson M, Harris WR, Halestrap AP. (2002). Aluminum citrate uptake by immortalized brain endothelial cells: implications for its blood-brain barrier transport. Brain Res 930:101-110
176. Yokel RA. (1994). Aluminum chelation: chemistry, clinical, and experimental studies and the search for alternatives to desferrioxamine. J Toxicol Environ Health 41:131-174
177. Yokel RA. (2000). The toxicology of aluminum in the brain: a review. Neurotoxicology 21:813-828
178. Yuan B, Klein MH, Contiguglia RS, Mishell JL, Seligman PA, Miller NL, Molitoris BA, Alfrey AC, Shapiro JI. (1989). The role of aluminum in the pathogenesis of anemia in an outpatient hemodialysis population. Ren Fail 11:91-96
179. Yumoto S, Nagai H, Imamura M, Matsukazi H, Hayashi K, Masuda A, Kumazawa H, Ohashi H, Kobayashi K. (1997). 26Al uptake and accumulation in the brain. Nucl Instrum Methods Phys Res B 123:279-282
180. Zhang ZJ, Qian YH, Hu HT, Yang J, Yang GD. (2003). The herbal medicine Dipsacus asper wall extract reduces the cognitive deficits and overexpression of beta-amyloid protein induced by aluminum exposure. Life Sci 73:2443-2454.